Stockreport

Xtant Medical Holdings Inc (XTNT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]

Xtant Medical Holdings, Inc.  (XTNT) 
US:NASDAQ Investor Relations: investor.xtantmedical.com
PDF Licensing Revenue: $5.5 million included in Q3 2025 revenue. Biologics Revenue Growth: 4% increase over Q3 2024. Gross Margin: 66.1%, up from 58.4% in Q3 2024. Op [Read more]